Willeman T, Grundig N, Pochon C, Michels D, Charpentier N, Eysseric-Guérin H, Fouilhé Sam-Lai N, Stanke-Labesque F, Revol B. NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users. Harm Reduct J. 2023 Jul 28;20(1):96. doi: 10.1186/s12954-023-00836-4. PMID: 37507699; PMCID: PMC10375651.
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users Lire la suite »
Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. Int J Drug Policy. 2023 Aug;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub 2023 Jun 8. PMID: 37336071; PMCID: PMC10247883.
Revol B, Willeman T, Manceau M, Dumestre-Toulet V, Gaulier JM, Fouilhé Sam-Laï N, Eysseric-Guérin H; Compagnie Nationale des Biologistes et Analystes Experts (CNBAE) and the French Addictovigilance Network (FAN). Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register. JAMA Netw Open. 2023 Aug 1;6(8):e2331398. doi: 10.1001/jamanetworkopen.2023.31398.
Perino J, Demourgues M, Ramaroson H, Bezin J, Micallef J, Miremont-Salamé G, Frauger E, Gilleron V, Ong N, Daveluy A. Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown. Public Health. 2023 Aug 10;223:1-6. doi: 10.1016/j.puhe.2023.07.004. Epub ahead of print. PMID: 37572562.
E. Frauger, N. Fouilhé, C. Lacroix et al., Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020, Therapies
Guerlais M, Aquizerate A, Lionnet A, Daveluy A, Duval M, Gérardin M, Istvan M, Laforgue EJ, Victorri-Vigneau C. for French Addictovigilance Network – Nitrous oxide: a unique official French addictovigilance national survey. Front Public Health. 2023 May 3;11:1167746. doi: 10.3389/fpubh.2023.1167746. PMID: 37206871; PMCID: PMC10189051.
Nitrous oxide: a unique official French addictovigilance national survey. Lire la suite »
Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. Int J Drug Policy. 2023 Jun 8;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub ahead of print. PMID: 37336071; PMCID: PMC10247883.
Roy S, Eiden C, Nogue E, Picot MC, Donnadieu-Rigole H, Peyrière H. Follow-up of patients hospitalized for cocaine detoxification. Inpatient cocaine detoxification. Therapie. 2022 Dec 2:S0040-5957(22)00271-2. doi: 10.1016/j.therap.2022.11.008. Epub ahead of print. PMID: 36517301.
Mezaache S, Turlure F, Fredon N, Le Brun Gadelius M, Micallef J, Frauger E. Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie [Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres]. Therapie. 2023 Mar 15:S0040-5957(23)00057-4. French.
Aquizerate, A., Laforgue, EJ., Istvan, M. et al. Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study. Int J Ment Health Addiction (2023).